Maintenance therapy for patients with recurrent or metastatic cervical cancer: A multicentre, cohort study

被引：0
|
作者：
Peng, Chen
Guo, Qiufen
Zhang, Tingting
Chen, Jinlong
Liu, Naifu
Yan, Peile
Lu, Yuanyuan
Ma, Anqun
Lv, Pengzhong
Liu, Jing
Xie, Peng
机构：
[1] Shandong First Med, Shandong Canc Hosp, Jinan, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[3] Jilin Univ, Dept Gastrointestinal Colorectal & Anal Surg, China Japan Union Hosp, Changchun, Peoples R China
[4] Wannan Med Coll, Dept Radiat Oncol, Affiliated Hosp 1, Wuhan, Peoples R China
[5] Shandong First Med Univ, Dept Thorac Surg, East Hosp, Affiliated Prov Hosp, Jinan, Peoples R China
[6] Shandong First Med Univ, Dept Gynecol, Affiliated Hosp 1, Jinan, Peoples R China
[7] Shandong Prov Qianfoshan Hosp, Jinan, Peoples R China
[8] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiat Oncol, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17518
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
    Colombo, N.
    Dubot, C.
    Lorusso, D.
    Caceres, M., V
    Hasegawa, K.
    Shapira-Frommer, R.
    Tewari, K. S.
    Salman, P.
    Usta, E. Hoyos
    Yanez, E.
    Gumus, M.
    de Mendoza, M. Olivera Hurtado
    Samouelian, V
    Castonguay, V
    Arkhipov, A.
    Toker, S.
    Li, K.
    Keefe, S. M.
    Monk, B. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (20): : 1856 - 1867
  • [32] Immunotherapy for Recurrent and Metastatic Cervical Cancer: A Review
    Wu, Yuke
    He, Xiang
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (07):
  • [33] The Role of Immunotherapy in Recurrent or Metastatic Cervical Cancer
    Randall, Leslie M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (07) : 435 - 437
  • [34] Current management of recurrent/metastatic cervical cancer
    Tewari, Krishnansu Sujata
    ANNALS OF ONCOLOGY, 2023, 34 : S1358 - S1358
  • [35] Tisotumab vedotin in recurrent or metastatic cervical cancer
    Bogani, Giorgio
    Coleman, Robert L.
    Vergote, Ignace
    Raspagliesi, Francesco
    Lorusso, Domenica
    Monk, Bradley J.
    CURRENT PROBLEMS IN CANCER, 2023, 47 (03)
  • [36] Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
    Colombo, Nicoletta
    Dubot, Coraline
    Lorusso, Domenica
    Caceres, M. Valeria
    Hasegawa, Kosei
    Shapira-Frommer, Ronnie
    Tewari, Krishnansu S.
    Salman, Pamela
    Usta, Edwin Hoyos
    Yanez, Eduardo
    Gumus, Mahmut
    de Mendoza, Mivael Olivera Hurtado
    Samouelian, Vanessa
    Castonguay, Vincent
    Arkhipov, Alexander
    Toker, Sarper
    Li, Kan
    Keefe, Stephen M.
    Monk, Bradley J.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (01) : 30 - 31
  • [37] Guidelines for the treatment of recurrent and metastatic cervical cancer
    Friedlander, M
    ONCOLOGIST, 2002, 7 (04): : 342 - 347
  • [38] Therapy for Patients with recurrent and metastatic Endometrial Cancer: A Case Report
    Huwer, S., I
    Jung, L.
    Huwer, H.
    Juhasz-Boess, I
    Solomayer, E. F.
    Breitbach, G. P.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E251 - E251
  • [39] Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study
    Yonemori, Kan
    Kuboki, Yasutoshi
    Hasegawa, Kosei
    Iwata, Takashi
    Kato, Hidenori
    Takehara, Kazuhiro
    Hirashima, Yasuyuki
    Kato, Hisamori
    Passey, Chaitali
    Buchbjerg, Jeppe Klint
    Harris, Jeffrey R.
    Andreassen, Camilla Mondrup
    Nicacio, Leonardo
    Soumaoro, Ibrahima
    Fujiwara, Keiichi
    CANCER SCIENCE, 2022, 113 (08) : 2788 - 2797
  • [40] Maintenance therapy for metastatic colorectal cancer
    Giampieri, Riccardo
    Cascinu, Stefano
    LANCET ONCOLOGY, 2015, 16 (13): : 1281 - 1282
12345